Page last updated: 2024-11-05

4-hydroxymercuribenzoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID23667696
SCHEMBL ID1508077
MeSH IDM0096665

Synonyms (23)

Synonym
p-chloromercuribenzoic acid sodium salt
nsc 1048
mercury, (p-carboxyphenyl)hydroxy-, monosodium salt
sodium 4-hydroxymercuriobenzoate
einecs 205-340-5
sodium (4-carboxylatophenyl)hydroxymercurate(1-)
ai3-62333
mercury, (p-carboxyphenyl)hydroxy-, sodium salt
4-hydroxymercuribenzoate
sodium 4-(hydroxymercuri)benzoic acid
mercurate(1-), (4-carboxylatophenyl)hydroxy-, sodium
138-85-2
SGCUT00231
TO_000057
4-(hydroxymercuri)benzoic acid sodium salt, >=95.0% (hg)
unii-8i6993tikc
mercurate(1-), (4-carboxylatophenyl)hydroxy-, sodium (1:1)
4-(hydroxymercury)benzoic acid sodium salt
4-(hydroxymercuri)benzoic acid sodium salt
DTXSID3059684
SCHEMBL1508077
sodium (4-carboxylatophenyl)(hydroxy)mercury
sodium;(4-carboxylatophenyl)mercury;hydrate

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The dose-response of both substances reveal saturation curves."( Osmotica, dimethyl sulfoxide, parahydroxymercuribenzoate, and cyanide change the period of the circadian clock in the pulvini of Phaseolus coccineus L.
Flach, D; Maier, M; Mayer, WE, 1985
)
0.27
" In addition to a ouabain-insensitive Mg-ATPase, ouabain dose-response curves have suggested the presence, in brain, of two NaK-ATPase activities with different sensitivities to ouabain."( Brain NaK-ATPases in mice differentially sensitive to alcohols.
Collins, AC; Marks, MJ; Smolen, A,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (202)

TimeframeStudies, This Drug (%)All Drugs %
pre-199087 (43.07)18.7374
1990's62 (30.69)18.2507
2000's35 (17.33)29.6817
2010's18 (8.91)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (0.98%)6.00%
Case Studies2 (0.98%)4.05%
Observational0 (0.00%)0.25%
Other200 (98.04%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]